Clinical Trials Directory

Trials / Conditions / Granuloma Annulare

Granuloma Annulare

10 registered clinical trials studyying Granuloma Annulare.

StatusTrialSponsorPhase
WithdrawnTyrosine Kinase 2 (TYK2) for GA and CS
NCT06725264
Yale UniversityPhase 2
CompletedUsing Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care
NCT07428954
AI Labs Group S.L—
Active Not RecruitingJanus Kinase Inhibition in Granuloma Annulare
NCT05650736
William DamskyPhase 2
CompletedStudy to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare
NCT05580042
TWi Biotechnology, Inc.Phase 1
CompletedEvaluation of 41 Cases of Pediatric Granuloma Annulare
NCT05472636
Istanbul Training and Research Hospital—
CompletedOpen-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
NCT03910543
Yale UniversityPhase 1
CompletedPain Outcomes Following Intralesional Corticosteroid Injections
NCT03630198
Vanderbilt University Medical CenterPhase 4
CompletedGranuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
NCT00720980
Henry Ford Health System—
CompletedUltraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
NCT00129428
University of MichiganPhase 1 / Phase 2
TerminatedUVA1 Light for Scleroderma and Similar Conditions
NCT00476697
University of MichiganN/A